Current guidelines lack consensus and rely on lower-quality evidence, according to the author of new research.

A new study has found that an experimental drug appears to reduce the risk of Alzheimer’ s-related dementia in people ...

The newest cost savings estimates from DOGE took 3 Mississippi Social Security offices and an Inspector General office off ...

One of the vaccines for a specific strain of an avian virus could come from a research lab on the campus of South Dakota ...

Payment will be provided when TTVR is delivered for an FDA-approved indication in the context of a CMS-approved study.

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in ...

President Donald Trump and Republicans are at a record high with voters as Democrats falter in the eyes of voters.

American take part in a poll about their views on different government programs and the funding that DOGE is currently ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB)Phase 2 SHINE Data Show Dramatic Slowing of ...

Noida: The Government Institute of Medical Sciences (GIMS) blood centre has identified a rare A3 blood subgroup in a donor from Aligarh. While blood groups are usually categorised into A ...